Evidence map›Paper›PMID 40794788›Full record

ArticlePLoS pathogens2025

Yersinia actively downregulates type III secretion and adhesion at higher cell densities.

Francesca Ermoli, Gabriele Malengo, Christoph Spahn, Corentin Brianceau, Timo Glatter, Andreas Diepold

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Proteomic Analysis of the Differential Response ofAntibiotics (Basel, Switzerland) · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Francesca ErmoliDepartment of Ecophysiology, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.
Gabriele MalengoCore Facility for Flow Cytometry and Imaging, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.
Christoph SpahnDepartment of Natural Products in Organismic Interactions, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.
Corentin BrianceauDepartment of Applied Biology, Institute of Applied Biosciences, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Timo GlatterCore Facility for Mass Spectrometry and Proteomics, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.
Andreas DiepoldDepartment of Ecophysiology, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.ORCID 0000-0002-4475-3923

Funding

Max-Planck-Gesellschaft
6 · The paper itself

Abstract

The T3SS injectisome is used by Gram-negative bacteria, including important pathogens, to manipulate eukaryotic target cells by injecting effector proteins. While in some bacterial species, T3SS-negative bacteria benefit from the activity of their T3SS-positive siblings, the T3SS model organism Yersinia enterocolitica was thought to uniformly express and assemble injectisomes. In this study, we found that Yersinia actively suppress T3SS expression, assembly and activity at higher cell densities, such as inside microcolonies. This effect is highly specific to the T3SS, reversible, and distinct from stationary phase adaptation. It is conferred by the main T3SS transcription factor VirF, which is downregulated at higher densities and whose in trans expression restores T3SS activity. The concomitant downregulation of the VirF-dependent adhesin YadA led to a drastic reduction in bacterial cell adhesion. We propose that this active suppression of T3SS secretion and cell attachment at higher local bacterial densities promotes a switch during Yersinia infection from a T3SS-active colonization stage to a bacterial replication and dissemination phase.

Indexed as

Bacterial AdhesionBacterial ProteinsGene Expression Regulation, BacterialYersinia enterocoliticaYersinia InfectionsAdhesins, BacterialDown-RegulationHumansTranscription FactorsAdhesins, BacterialBacterial ProteinsTranscription FactorsYadA protein, Yersinia

Identifiers

PMID40794788
PMCPMC12404644

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.